Auris Surgical Robotics has stealthily raised a massive $280 million in a Series D round of financing, according to the company’s website and an SEC filing posted today.
Money in the round came from 39 investors, led by newly invested Coatue Management and joined by Mithril, Lux Capital and Highland Capital Partners, according to the filing and the company’s website.
The company is looking to raise an additional $4.9 million before closing the round, with the 1st sale recorded on April 5, according to the SEC filing.
Auris Surgical is developing a robotic platform with an initial focus on lung cancer, having won FDA clearance for an Ares robot-assisted bronchoscopy platform last June.
The company claims the platform “integrates the latest advancements in robotics, micro-instrumentation, sensing, and data science to achieve these breakthroughs and deliver dramatically improved clinical outcomes for patients,” according to its website.
The company, co-founded by medical robotics pioneer Dr. Frederic Moll, turned heads when it bought Hansen Medical, which Moll co-founded, for $80 million last April.
Moll has been an important factor in multiple startups in medical devices, and specifically robotics, including market leader Intuitive Surgical (NSDQ:ISRG), Mako Surgical, acquired in 2013 for $1.7 billion by Stryker(NYSE:SYK) and Restoration Robotics and its Artas hair restoration platform.
Auris revealed in a September 2015 regulatory filing that it reeled in a $150 million funding round from 25 unnamed investors. And in April 2014, Auris said it raised more than $34 million in an equity round from 20 backers; that filing listed several executives from private equity shops as directors, including Ajay Royan of Mithril Capital Management, Robert Higgins of Highland Capital Partners, Peter Hébert of Lux Capital and Dr. Bijan Salehizadeh of the NaviMed Capital.